StockNews.AI
MRNA
Benzinga
18 days

Moderna Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

1. Moderna will report Q2 earnings on August 1. 2. Analysts expect a loss of $2.97 per share. 3. Projected revenue is $112.96 million, down from $241 million. 4. Company plans to cut workforce by 10% due to declining vaccine sales. 5. Shares dropped 8.1% to $29.56 recently.

4m saved
Insight
Article

FAQ

Why Bearish?

Analysts' downgrades and reduced price targets reflect concerns over sales decline, similar to past trends like 2022's decline post-vaccine rollout.

How important is it?

The article highlights significant earnings projections and workforce reduction, directly impacting investor sentiment and future forecasts.

Why Short Term?

Immediate earnings report could trigger further stock price reactions, reminiscent of past earnings disappointments.

Related Companies

Related News